abstract |
The invention relates to the use of at least one oligosaccharide comprising from 2 to 7 osidic residues, and having a galactose residue in a non-reducing terminal position, or of a derivative of such an oligosaccharide substituted by a hydrophobic residue, for the preparation of an immunomodulatory drug. It also relates to a dermato-cosmetic composition and a method of cosmetic treatment of hyperreactive skin. |